FT-4202, a selective pyruvate kinase R activator for sickle cell disease.
Ericsson A, Richard DJ, Wilker E, Lancia DR Jr, Fessler S, Troccolo P, Zheng X, Toms A, Dinsmore C, Yao L, Kuypers FA, Larkin S, Marcotte D, Fulzele K, Ribadeneira M, Guichard SM, Marshall G.
Ericsson A, et al. Among authors: toms a.
Exp Hematol. 2025 Jan;141:104673. doi: 10.1016/j.exphem.2024.104673. Epub 2024 Nov 15.
Exp Hematol. 2025.
PMID: 39549740
Free article.